PAPER Alam J, Jiang Y, Nixon R

Antagonism of p38 MAPK Alpha (p38α) Reverses APP-Induced Endosomal Abnormalities and Improves Lysosomal Function in Down Syndrome Fibroblasts

Alzheimer's & Dementia Supplement, July 2017 .

PAPER Xia D, Lianoglou S, Sandmann T, Calvert M, Suh JH, Thomsen E, Dugas J, Pizzo ME, DeVos SL, Earr TK, Lin C-C, Davis S, Ha C, Nguyen H, Chau R, Yulyaningsih E, Solanoy H, Masoud ST, Liang R, Lin K, Thorne RG, Garceau D, Whitesell JD, Sasner M, Harris JA, Scearce-Levie K, Lewcock JW, Gilbert Di Paolo G, Sanchez PE

Fibrillar Aβ causes profound microglial metabolic perturbations in a novel APP knock-in mouse model

bioRxiv. January 20, 2021. .

PAPER Marinaro F, Haneklaus M, Zhang Z, Strano A, Evans L, Handfield L-F, Ryan NS, Fox NC, Hemberg M, Ramanathan S, Livesey FJ

Molecular and cellular pathology of monogenic Alzheimer’s disease at single cell resolution

bioRxiv. July 14, 2020. . BioRxiv.

PAPER Serrano GE, Walker JE, Intorcia AJ, Glass MJ, Arce RA, Piras IS, Talboom JS, Nelson CM, Cutler BD, Sue LI, Lue L-F, Huentelman M, Beach TG

Whole-Cell Dissociated Suspension Analysis in Human Brain Neurodegenerative Disease: A Pilot Study

medRxiv. January 9, 2021. . medRxiv.

PAPER Kang SS, Baker KE, Wang X, Kocher J-P, Fryer JD

Translational profiling of microglia reveals artifacts of cell sorting

bioRxiv, May 9, 2017. .

PAPER Hou R, Yu Y, Nguyen DT, Sluter MN, Li L, YanLig J, Jiang J

Prostaglandin receptor EP2 is a novel molecular target for high-risk neuroblastoma

bioRxiv. February 25, 2020. .

PAPER Sipilä PN, Heikkilä N, Lindbohm JV, Hakulinen C, Vahtera J, Elovainio M, Suominen S, Väänänen A, Koskinen A, Nyberg ST, Pentti J, Strandberg TE, Kivimäki M

Hospital-treated infectious diseases and the risk of dementia: multicohort study with replication in the UK Biobank

MedRxiv. Posted April 24, 2020. doi.org/10.1101/2020.04.20.20072355 . medRxiv.

PAPER Pilotto A, Cristillo V, Piccinelli SC, Zoppi N, Bonzi G, Sattin D, Schiavolin S, Raggi A, Canale A, Gipponi S, Libri I, Frigerio M, Bezzi M, Leonardi M, Padovani A

COVID-19 severity impacts on long-term neurological manifestation after hospitalisation

MedRxiv. Posted January 02, 2021. doi.org/10.1101/2020.12.27.20248903 . medRxiv.

PAPER Yang C, Farias FG, Ibanez L, Sadler B, Fernandez MV, Wang F, Bradley JL, Eiffert B, Bahena JA, Budde JP, Li Z, Dube U, Sung YJ, Mihindukulasuriya KA, Morris JC, Fagan A, Perrin RJ, Benitez B, Rhinn H, Harari O, Cruchaga C

Genomic and multi-tissue proteomic integration for understanding the biology of disease and other complex traits

MedRxiv. 2020 Jun 26. . medRxiv.

PAPER Xia D, Lianoglou S, Sandmann T, Calvert M, Suh JH, Thomsen E, Dugas J, Pizzo ME, DeVos SL, Earr TK, Lin CC, Davis S, Ha C, Nguyen H, Chau R, Yulyaningsih E, Solanoy H, Masoud ST, Liang R, Lin K, Thorne RG, Garceau D, Whitesell JD, Sasner M, Harris JA, Scearce-Levie K, Lewcock JW, Di Paolo G, Sanchez PE

Fibrillar Aβ causes profound microglial metabolic perturbations in a novel APP knock-in mouse model

bioRxiv. January 20, 2021. .

PAPER He L, Mäe MA, Muhl L, Sun Y, Pietilä R, Nahar K, Vázquez Liébanas E, Fagerlund MJ, Oldner A, Liu J, Genové G, Zhang L, Xie Y, Leptidis S, Mocci G, Stritt S, Osman A, Anisimov A, Hemanthakumar KA, Räsänen R, Mirabeau O, Hansson E, Björkegren J, Vanlandewijck M, Blomgren K, Mäkinen T, Peng XR, Arnold TD, Alitalo K, Lendahl U, Betsholtz C

Pericyte-specific vascular expression of SARS-CoV-2 receptor ACE2 – implications for microvascular inflammation and hypercoagulopathy in COVID-19

bioRxiv, July 26, 2020. . bioRxiv.

PAPER Bellenguez C, Küçükali F, Jansen I, Andrade V, Moreno-Grau S, Amin N, Naj AC, Grenier-Boley B, Campos-Martin R, Holmans PA, Boland A, Kleineidam L, Damotte V, van der Lee SJ, Kuulasmaa T, Yang Q, de Rojas I, Bis JC, Yaqub A, ... Lambert, JC

New insights on the genetic etiology of Alzheimer’s and related dementia

medRxiv. 2020 Dec 14. . medRxiv

PAPER Sandor C, Millin S, Dahl A, Lawton M, Hubbard L, Bojovic B, Peyret-Guzzon M, Matten H, Blancher C, Williams N, Ben-Shlomo Y, Hu MT, Grosset DG, Marchini J, Webber C

Universal latent axes capturing Parkinson’s patient deep phenotypic variation reveals patients with a high genetic risk for Alzheimer’s disease are more likely to develop a more aggressive form of Parkinson’s

bioRxiv. February 18, 2021 .

PAPER Haynes BA, Rhinn H, Yeh FL, Long H, Ward M, Hagey M, Siddiqui O, Paul R

AL001 restores CSF PGRN levels and normalizes disease‐associated biomarkers in individuals with frontotemporal dementia due to heterozygous mutations in the progranulin gene

Alzheimer's & Dementia, 7 December 2020 .

PAPER Alam R, Driver D, Wu S, Lozano E, Key SL, Hole JT, Hayashi ML, Lu J

[O2–14–05]: Preclinical Characterization of an Antibody [LY3303560] Targeting Aggregated Tau

Alzheimer's & Dementia, July 2017 .